Protalix BioTherapeutics (PLX) Net Margin Growth (1y) (2011 - 2026)
Protalix BioTherapeutics (PLX) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,245.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,120.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Protalix BioTherapeutics |
176.47 Mn |
165.67 Mn |
29.62 Mn |
9,006.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
9,006.00 |
| Dec 31, 2025 |
-10,659.00 |
| Sep 30, 2025 |
-450.00 |
| Jun 30, 2025 |
1,887.00 |
| Mar 31, 2025 |
8,681.00 |
| Dec 31, 2024 |
29,547.00 |
| Sep 30, 2024 |
3,592.00 |
| Jun 30, 2024 |
-6,256.00 |
| Mar 31, 2024 |
-8,994.00 |
| Dec 31, 2023 |
-19,890.00 |
| Sep 30, 2023 |
725.00 |
| Jun 30, 2023 |
10,715.00 |
| Mar 31, 2023 |
-1,844.00 |
| Dec 31, 2022 |
4,011.00 |
| Sep 30, 2022 |
1,048.00 |
| Jun 30, 2022 |
11,596.00 |
| Mar 31, 2022 |
3,756.00 |
| Dec 31, 2021 |
-7,900.00 |
| Sep 30, 2021 |
658.00 |
| Jun 30, 2021 |
-13,871.00 |
